Risk factors for cardiovascular disease in systemic lupus erythematosus

Circulation

Volumn 104, Issue 16, 2001, Pages 1887-1893

  Svenungsson, Elisabet ^a   Jensen Urstad, Kerstin ^a   Heimbürger, Mikael ^a   Silveira, Angela ^a   Hamsten, Anders ^a   De Faire, Ulf ^a   Witztum, Joseph L ^b   Frostegård, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Atherosclerosis; Cardiovascular diseases; Risk factors; Ultrasonics

Indexed keywords

ALPHA 1 ANTITRYPSIN; AUTOANTIBODY; EPITOPE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN; LUPUS ANTICOAGULANT; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; PREDNISOLONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; HIGH RISK POPULATION; HUMAN; INTIMA; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND;

EID: 0035899949     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4101.097518     Document Type: Article

References (29)

1. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study
2. Dyslipoproteinemias in systemic lupus erythematosus: Influence of disease, activity, and anticardiolipin antibodies
3. Lipoprotein(a) levels in systemic lupus erythematosus
4. Is type II diabetes mellitus a disease of the innate immune system?
5. Atherosclerosis: An inflammatory disease
6. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
7. Induction of T-cell activation by oxidized low density lipoprotein
8. The oxidation hypothesis of atherosclerosis
9. The 1982 revised criteria for classification of systemic lupus erythematosus
10. Measurement of systemic lupus erythematosus activity in clinical research
11. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology
12. Lipoprotein fractionation
13. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
14. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension
15. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
16. Carotid intima-media thickness and plaque in borderline hypertension
17. Anti-phospholipid anti-bodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H)
18. Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus
19. Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events
20. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
21. Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein
22. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in SLE
23. Homocyst(e)ine, and cardiovascular disease: A critical review of the epidemiologic evidence
24. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
25. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels
26. Anti-inflammatory drugs in experimental atherosclerosis, 7: Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate
27. Progression of aortic calcification is associated with metacarpal bone loss during menopause: A population-based longitudinal study
28. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
29. Arterial disease in lupus and secondary antiphospholipid syndrome: Association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein